Since the patient in this case study was hyperlipidemic due to concurrent hypothyroidism, the author explains in the following literature review section how chlorambucil works perfectly—not tyrosine kinase inhibitors—in cases of hyperlipidemia, with a focus on the RAS-RAF-MEK pathway. Here, MAP2K7 is linked to hyperlipidemia.